• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CHP Merger Corp. Provides Update on Periodic Reporting

    5/28/21 4:30:00 PM ET
    $CHPM
    Get the next $CHPM alert in real time by email

    SUMMIT, N.J., May 28, 2021 /PRNewswire/ -- As previously announced on May 21, 2021, CHP Merger Corp. (NASDAQ:CHPM) (the "Company") has determined to restate its 2019 and 2020 financial statements (the "Non-Reliance Periods") in light of the U.S. Securities and Exchange Commission's (the "SEC") recently issued "Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs")" (the "Staff Statement"). This Staff Statement issued on April 12, 2021 informed market participants that warrants issued by SPACs and former SPACs may need to be reclassified as liabilities with non-cash fair value adjustments recorded in earnings at each reporting period. The Company had previously classified its issued warrants as equity. The Company currently expects that the reclassification of the warrants will have no impact on its historical liquidity, cash flows or revenues.

    The Company is working diligently with its auditors in order to finalize and to file an amendment to its Annual Report on Form 10-K for the year ended December 31, 2020 (the "Form 10-K/A") reflecting the reclassification of the warrants for the Non-Reliance Periods as soon as practicable. The adjustments to the financial statement items for the Non-Reliance Periods will be set forth through disclosures in the financial statements included in the Form 10-K/A.

    Given the time and focus dedicated to the restatement process and the completion and filing of the Company's Form 10-K/A, the Company requires additional time to complete its customary quarterly review and reporting process and the filing of its Form 10-Q for the first quarter ended March 31, 2021 (the "Form 10-Q") and was unable to file the Form 10-Q by the May 17, 2021 deadline. As a result, the Company received a Notification of Deficiency by the Listing Qualifications Department at Nasdaq on May 26, 2021 indicating that it is in violation of Nasdaq Listing Rule 5250(c)(1). The Form 10-Q will be filed as soon as is practicable after the filing of the Form 10-K/A.

    About CHP Merger Corp.

    CHP Merger Corp. is a Special Purpose Acquisition Vehicle formed by an affiliate of Concord Health Partners ("Concord").  While the Company may pursue an initial business combination in any sector, it intends to focus its search on target businesses in the healthcare or healthcare-related industries in the United States. Concord, a healthcare-focused investment firm with a strategic approach that aligns interests between investors and portfolio companies, is primarily focused on investing in companies that have the potential to enhance the value of care through technologies and solutions that lower costs, improve quality and/or expand access to care.

    Forward-Looking Statements

    This press release may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus relating to the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    Contacts

    Investor Contact

    James Olsen

    [email protected]

    Media Contact

    Steve Bruce / Taylor Ingraham

    ASC Advisors

    [email protected] / [email protected]

    Cision View original content:http://www.prnewswire.com/news-releases/chp-merger-corp-provides-update-on-periodic-reporting-301301897.html

    SOURCE CHP Merger Corp

    Get the next $CHPM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHPM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CHPM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Accelus and CHP Merger Corp. Mutually Agree To Terminate Business Combination

      PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) -- Integrity Implants Inc. d/b/a Accelus ("Accelus"), a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, and CHP Merger Corp. ("CHP") (NASDAQ:CHPM, CHPMU and CHPMW))), a special purpose acquisition company (SPAC), announced today that the companies have mutually agreed to terminate, effective immediately, the previously announced business combination agreement dated November 14, 2021 as a result of market conditions. "In light of market conditions, we believe that this strategic pivot will best enable our team to exe

      4/15/22 4:00:33 PM ET
      $CHPM
    • CHP Merger Corp. Announces Approval of Extension Proposal

      SUMMIT, N.J., Nov. 24, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it held a special meeting of stockholders (the "Special Meeting") relating to the proposal (the "Extension Proposal") to amend the Company's amended and restated certificate of incorporation to extend the date by which the Company must complete its initial business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S. based medical technology company focused on the spinal surgery market (the "Accelus Business Combination") from November 26, 2021 to May 26, 2022 (the "Extension"), which the stockholders voted to approve. The Extension Proposal is described in fu

      11/24/21 5:00:00 PM ET
      $CHPM
    • CHP Merger Corp. Announces Adjournment of its Special Meeting

      SUMMIT, N.J., Nov. 22, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it convened and then adjourned, without conducting any other business, the Company's special meeting of stockholders (the "Special Meeting") held on November 22, 2021. The Special Meeting has been adjourned until November 24, 2021 at 9:00 a.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to vote on the proposal to extend the date by which the Company must consummate the previously announced business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S.-based medical technology company focused on the spinal surgery market (the "Accelus Bus

      11/22/21 3:15:00 PM ET
      $CHPM

    $CHPM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Magnetar Financial Llc disposed of $23,918,851 worth of shares (2,342,184 units at $10.21)

      4 - CHP Merger Corp. (0001785041) (Issuer)

      4/27/22 5:50:03 PM ET
      $CHPM
    • SEC Form 3: New insider Magnetar Financial Llc claimed ownership of 2,342,184 shares

      3 - CHP Merger Corp. (0001785041) (Issuer)

      4/7/22 5:16:11 PM ET
      $CHPM

    $CHPM
    SEC Filings

    See more
    • SEC Form 15-12B filed by CHP Merger Corp.

      15-12B - CHP Merger Corp. (0001785041) (Filer)

      5/3/22 12:36:33 PM ET
      $CHPM
    • SEC Form RW filed by CHP Merger Corp.

      RW - CHP Merger Corp. (0001785041) (Filer)

      5/3/22 12:29:59 PM ET
      $CHPM
    • SEC Form 25-NSE filed by CHP Merger Corp.

      25-NSE - CHP Merger Corp. (0001785041) (Subject)

      4/22/22 4:22:33 PM ET
      $CHPM

    $CHPM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CHP Merger Corp. (Amendment)

      SC 13G/A - CHP Merger Corp. (0001785041) (Subject)

      5/2/22 4:15:26 PM ET
      $CHPM
    • SEC Form SC 13G/A filed by CHP Merger Corp. (Amendment)

      SC 13G/A - CHP Merger Corp. (0001785041) (Subject)

      4/11/22 5:05:50 PM ET
      $CHPM
    • SEC Form SC 13G/A filed by CHP Merger Corp. (Amendment)

      SC 13G/A - CHP Merger Corp. (0001785041) (Subject)

      4/7/22 5:00:51 PM ET
      $CHPM